Any

Video explores and challenges ideas about Black men and how they address health issues.

Presents results from iSpeak, a research study implemented in 2011 to understand HIV-related needs, challenges and priorities of heterosexual Black men in Ontario.

The guide addresses the realities and complexities faced by nurses who provide care to people living with HIV. The aim of the guide is to offer practical advise to HIV nurses and clarify professional obligations regarding HIV non-disclosure and the criminal law.

Dr. Peter Ford discusses the history of HIV care in Canadian prisons in a presentaion from the Inside and Out Conference, a meeting to discuss the HIV prevention, engagement and care cascade for current and former prisoners

The factors impacting vulnerability to HIV and other STBBI are provided to help foster discussion about the factors that impact vulnerability for priority populations.

TJ Parsell speaks about his experience in prison, sexual assault in prison, prisoner rape from the Insight & Out Conference.

The Response provides access to research evidence in response to questions from community-based organizations to help provide insight on a particular issue or build community capacity

This webinar provides the medical and scientific evidence behind Truvada for HIV PrEP. CTAC contributes patient input to reviews of new HIV drugs and contributes to CADTH’s Therapeutic Review of all hepatitis C drugs

A community based intervention research study to address HIV stigma through collective empowerment, capacity building, and community championship. CHAMP evaluated the effectiveness of two stigma-reduction interventions study in reducing HIV stigma: Acceptance Commitment Training and Social Justice Capacity Building. Read more of the article: Community Champions HIV/AIDS Advocates Mobilization Project (CHAMP): Reducing HIV Stigma and Advancing Equity Through Committed Action

The paper determines whether expanding Insite (North American’s first and only supervised injection facility) to more locations in Canada such as Montreal, cost less than the health care consequences of not having such expanded programs for injection drug users.